Microarray Technology Applied to Human Allergic Disease

Area of Science:

• Immunology
• Allergy diagnostics
• Biotechnology

Background:

• Immunoglobulin E (IgE) antibodies mediate allergic reactions by triggering mast cells and basophils.
• Early microarray assays utilized chip technology with purified allergens to detect IgE.
• These assays enable simultaneous analysis of multiple allergen-specific IgE antibodies.

Purpose of the Study:

• To describe the development and application of microarray-based IgE antibody assays.
• To evaluate the utility of microarray assays in identifying patient sensitization profiles.
• To compare the performance of microarray assays with singleplex methods.

Main Methods:

• Immobilization of over 100 allergenic molecules on glass slides.
• Detection of bound human IgE and IgG antibodies using fluorescently labeled anti-human IgE.
• Analysis of fluorescent profiles to determine allergen-specific IgE profiles, including cross-reactivity.

Main Results:

• Microarray assays can identify IgE antibodies binding to single or multiple allergens, including cross-reactive families.
• The assay provides a sensitization profile for allergic patients.
• Microarray assays are less sensitive and quantitative than singleplex assays like ImmunoCAP and Immulite.

Conclusions:

• Chip-based microarray assays are effective research tools for defining population sensitization profiles in epidemiological studies.
• Despite limitations in sensitivity and quantification compared to singleplex assays, microarrays offer a high-throughput method for analyzing IgE specificities.
• Microarray technology has advanced allergy diagnostics by enabling comprehensive analysis of allergen-specific IgE.